Concepedia

Brett M. Antonio

BM

13

Publications

707

Citations

12

H-Index

2003

Active since

Affiliations

Pfizer (United States)(Current)

Pfizer (United Kingdom)

Florey Institute of Neuroscience and Mental Health

Wave Computation Technologies (United States)

Collaborations Pharmaceuticals (United States)

Brett M. Antonio is an author at Pfizer (United States) specializing in molecular pharmacology, medicine, and pharmacology.

Top concepts

Publications per year

2003–2024

13

Publications

13

Voltage sensor interaction site for selective small molecule inhibitors of voltage-gated sodium channels

Ken McCormack, Sonia Santos, Mark L. Chapman et al. · Proceedings of the National Academy of Sciences · 2013 · 240 citations · Full text

A novel selective and orally bioavailable <scp>N</scp> a <scp> <sub>v</sub> </scp> 1.8 channel blocker, <scp>PF</scp> ‐01247324, attenuates nociception and sensory neuron excitability

C. Elizabeth Payne, Adam R. Brown, Jonathon W Theile et al. · British Journal of Pharmacology · 2015 · 96 citations · Full text

GI‐530159, a novel, selective, mechanosensitive two‐pore‐domain potassium (K<sub>2P</sub>) channel opener, reduces rat dorsal root ganglion neuron excitability

Alexandre Loucif, Pierre‐Philippe Saintot, Jia Liu et al. · British Journal of Pharmacology · 2017 · 52 citations · Full text

Discovery of the First Orally Available, Selective K<sub>Na</sub>1.1 Inhibitor: <i>In Vitro</i> and <i>In Vivo</i> Activity of an Oxadiazole Series

Andrew M. Griffin, Kristopher M. Kahlig, Robert J. Hatch et al. · ACS Medicinal Chemistry Letters · 2021 · 48 citations · Full text

Repurposing Approved Drugs as Inhibitors of Kv7.1 and Nav1.8 to Treat Pitt Hopkins Syndrome

Sean Ekins, Jacob Gerlach, Kimberley M. Zorn et al. · Pharmaceutical Research · 2019 · 47 citations · Full text

, , +4

Rows per page

1–5 of 13